QIMA Life Sciences Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $61.6K
Latest Deal Amount
  • Investors
  • 1

QIMA Life Sciences General Information

Description

Developer of drugs intended to help the pharmaceutical industry. The company's services focus on studies applied to biomarkers in many areas: human & veterinary pharmaceuticals, dermo-cosmetics, and nutraceuticals, enabling biomarkers to be helped in identifying lead drug candidates by predicting toxicological effects.

Contact Information

Formerly Known As
Synelvia
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 516 rue Pierre et Marie Curie
  • 31670 Labège
  • France
+33 05 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

QIMA Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 26-Mar-2018 $61.6K 000.00 Completed Startup
To view QIMA Life Sciences’s complete valuation and funding history, request access »

QIMA Life Sciences Executive Team (3)

Name Title Board Seat Contact Info
Nicolas Amalric Co-Founder & Chief Executive Officer
Alain Moga Co-Founder & Chief Scientific Officer
Andre Weil Ph.D Chief Business Officer
To view QIMA Life Sciences’s complete executive team members history, request access »

QIMA Life Sciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nubbo Accelerator/Incubator 000 0000 000000 0
To view QIMA Life Sciences’s complete investors history, request access »